Exact Mass: 402.2357
Exact Mass Matches: 402.2357
Found 315 metabolites which its exact mass value is equals to given mass value 402.2357
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Gamabufogenin
Gamabufogenin is a steroid lactone. It is functionally related to a bufanolide. Gamabufotalin is a natural product found in Bufotes viridis, Bufo, and other organisms with data available. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides Gamabufotalin (Gamabufagin), a main active compound isolated from Chinese medicine Chansu, has been shown to strongly inhibit cancer cell growth and inflammatory response. Gamabufotalin could inhibite angiogenesis by inhibiting the activation of VEGFR-2 signaling pathways. Gamabufotalin (Gamabufagin), a main active compound isolated from Chinese medicine Chansu, has been shown to strongly inhibit cancer cell growth and inflammatory response. Gamabufotalin could inhibite angiogenesis by inhibiting the activation of VEGFR-2 signaling pathways.
Telobufotoxin
Telocinobufagin is a steroid lactone. It is functionally related to a bufanolide. Telocinobufagin is a natural product found in Bufo gargarizans, Bufo bufo, and other organisms with data available. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides Telocinobufagin is one of anti-hepatoma constituent in Venenum Bufonis. Telocinobufagin is one of anti-hepatoma constituent in Venenum Bufonis.
ST 24:4;O5
C78276 - Agent Affecting Digestive System or Metabolism > C66913 - Cholagogues or Choleretic Agents D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids Same as: D01693
Lucidone A
Lucidone A is found in mushrooms. Lucidone A is a constituent of Ganoderma lucidum (reishi)
Cinitapride
Cinitapride is only found in individuals that have used or taken this drug.Cinitapride is a gastroprokinetic agent and antiulcer agent of the benzamide class which is marketed in Spain and Mexico. It acts as an agonist of the 5-HT1 and 5-HT4 receptors and as an antagonist of the 5-HT2 receptors. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cinitapride is a nonselective 5-HT1 and 5-HT4 receptors agonist and a 5-HT2 and D2 antagonist. Cinitapride can be used in functional dyspepsia (FD) and gastroesophageal reflux disease (GERD) research[1].
Gamabufotalin
Telocinobufagin
3-dehydrocholate
3-dehydrocholate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 3-dehydrocholate can be found in a number of food items such as kale, cucurbita (gourd), atlantic herring, and spearmint, which makes 3-dehydrocholate a potential biomarker for the consumption of these food products. Dehydrocholic acid is a synthetic bile acid, manufactured by the oxidation of cholic acid. It acts as a hydrocholeretic, increasing bile output to clear increased bile acid load .
Clascoterone
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen
17-Succinoyloxy-ent-cleroda-3,13(16),14-trien-15,16-oxide
3alpha,14alpha-Diacetoxy-2beta-hydroxy-1(15),8(19),9-trinervitatriene
N-(1-amino-4-hydroxy-3,3-dimethyl-1-oxobutan-2-yl)-1-((4-hydroxycyclohexyl)methyl)-1h-indazole-3-carboxamide
3alpha,9,14-Trihydroxy-5beta,14beta-bufa-20,22-dienolid|3alpha,9,14-trihydroxy-5beta,14beta-bufa-20,22-dienolide
1beta,11alpha-Diacetoxy-7-oxosandaracopimar-8(14),15-dien
7beta-angeloyloxy-8alpha-isobutyryloxylongipin-2-en-1-one
2-oxo-18,19-diacetoxy-10alpha,17alpha,19alpha,20beta-(-)-cleroda-3,13(16),14-triene
(-)-(5E,12E,2S,3S,4S,9S,11S,15R)-3,15-diacetoxylathyra-5,12-dien-14-one|3beta,15beta-diacetoxylathyra-5E,12E-dien-14-one|jolkinoate A
(2E,4E,6E)-6-(1-carboxyocta-2,4,6-triene)-11,12-epoxy-9-hydroxy-11-methoxy-drim-7-ene
6-O-alpha-E-p-coumaroyl-1beta,4alpha-dihydroxyeudesmane
2alpha-isobutyryloxy-15,16-epoxylabda-7,13(16),14-trien-18-oic acid
2-acetyl-3,5-dihydroxy-1-geranoxy-6-methyl-4-(2-methyl)butyryl-benzene
hexanocucurbitacin D|Hexanor-cucurbitacin D|Hexanorcucurbitacin D
(3beta,4beta,5beta,14beta)-3,4,14-Trihydroxybufa-20,22-dienolide
Di-Ac-7, 8-Epoxy-3, 12(18), 13-dolabellatriene-19, 20-diol
(1S,2R,3E,7E,11S,12R,13S)-2,13-diacetoxydolabella-3,7,18-trien-9-one
7alpha-hydroxy-8,11,13-abietatriene-18-succinic acid|abiesadine F
6alpha,12-diacetoxy-7beta-hydroxyabieta-8,11,13-triene|fortunin B
Hexanorcucurbitacin D
hexanorcucurbitacin D is a natural product found in Begonia parviflora, Cucumis melo, and other organisms with data available.
Dehydrocholic acid
Dehydrocholic acid is a synthetic bile acid, manufactured by the oxidation of cholic acid. It acts as a hydrocholeretic, increasing bile output to clear increased bile acid load. 3,7,12-trioxo-5beta-cholanic acid is an oxo-5beta-cholanic acid in which three oxo substituents are located at positions 3, 7 and 12 on the cholanic acid skeleton. It has a role as a gastrointestinal drug. It is an oxo-5beta-cholanic acid, a 7-oxo steroid, a 12-oxo steroid and a 3-oxo-5beta-steroid. It is a conjugate acid of a 3,7,12-trioxo-5beta-cholan-24-oate. Dehydrocholic acid is a synthetic bile acid that was prepared from the oxidation of cholic acid with chromic acid. It has been used for stimulation of biliary lipid secretion. The use of dehydrocholic acid in over-the-counter products has been discontinued by Health Canada.
(4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
3,7,12-Trioxo-5b-cholan-24-oic acid
BA-119-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-119-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-119-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
3,7,12-Trioxo-5a-cholan-24-oic acid
BA-128-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-128-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-128-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
Pregn-4-ene-3,20-dione, 6a,17-dihydroxy-6-methyl-, 17-acetate
Pregn-4-ene-3,20-dione, 6b,17-dihydroxy-6-methyl-, 17-acetate
7,21-Dihydroxy-6a-methylpregn-4-ene-3,20-dione 17-acetate
methyl ester
Cinitapride
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cinitapride is a nonselective 5-HT1 and 5-HT4 receptors agonist and a 5-HT2 and D2 antagonist. Cinitapride can be used in functional dyspepsia (FD) and gastroesophageal reflux disease (GERD) research[1].
lucidone A
4,4-di(2-ethylhexyl)-4H-cyclopenta[2,1-b:3,4-b]dithiophene
Bepridil hydrochloride
D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
17α-hydroxy-19-norpregna-5(10),9(11)-diene-3,20-dione 3,20-bis(ethylene acetal)
(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-diMethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester (2Z)-2-Methyl-2-butenoic Acid
Acacia senegal, ext.
Morpholine-4-carboxylic acid [1S-(2-benzyloxy-1R-cyano-ethylcarbamoyl)-3-methyl-butyl]amide
Clascoterone
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen
4-(cyclopropylmethyl)-1-(1H-pyrrolo[2,3-c]pyridin-3-ylmethyl)spiro[3,5-dihydro-1,4-benzoxazepine-2,4-piperidine]
(3E,5E,7E,10R,12Z,14E,17R,18S,22S)-22-ethyl-10,18-dihydroxy-17-methyl-1-oxacyclodocosa-3,5,7,12,14-pentaene-2,16-dione
ambiguine I
An ambiguine that consists of a 5,5,7,10,10-pentamethyl-4,5,5a,6a,6b,7,8,9,9a,10-decahydro-10dH-6-oxa-4-azacyclopropa[6,7]cyclohepta[1,2,3,4-mno]aceanthrylen-10d-ol skeleton with an ethenyl substituent at position 7 and an isocyano group at position 6b (the 5aS,6aR,6bR,7R,9aR,10dR stereoisomer). An antimicrobial agent isolated from the cyanobacterium strain Fischerella.
(3E,5E,9E,11Z,17E,19E)-8,14,16-trihydroxy-24-methyl-1-oxacyclotetracosa-3,5,9,11,17,19-hexaen-2-one
(-)-(5E,12E,2S,3S,4S,9S,11S,15R)-3,15-diacetoxylathyra-5,12-dien-14-one
A lathyrane diterpenoid isolated from the roots of Euphorbia micractina.
(4R)-4-[(10S,13R,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
1-[4-(2,3-Dimethylphenyl)piperazin-1-yl]-3-(4,4,6-trimethyl-2-sulfanylidene-1,3-diazinan-1-yl)propan-1-one
N-[6-amino-1-(2-methylpropyl)-2,4-dioxo-5-pyrimidinyl]-2-(2-methylphenoxy)-N-(2-methylpropyl)acetamide
(1R,2R,6R)-6-[(2E,6E,10E)-12-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-3-methyl-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate
4-[(5S,10S,13R,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
(1R,2S,6R)-3-methoxy-5-oxo-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate
N-[(3-methoxyphenyl)methyl]-1-[(1R)-1-naphthalen-1-ylethyl]piperidine-4-carboxamide
N-benzyl-N-[3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl]aniline hydrochloride
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide
N-[(2R,3S,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]pyridine-3-carboxamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]pyridine-3-carboxamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]pyridine-3-carboxamide
N-[(2S,3R,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2S,3S,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2S,3R,6R)-6-[2-[4-[(dimethylamino)methyl]triazol-1-yl]ethyl]-2-(hydroxymethyl)oxan-3-yl]-2-pyridin-3-ylacetamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide
N-[(2R,3R,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
(1S,2aS,8bS)-1-(hydroxymethyl)-2-[2-(4-morpholinyl)-1-oxoethyl]-N-propyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
1-[(3aR,4R,9bR)-8-(1-cyclohexenyl)-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide
N-[(2R,3S,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2S,3S,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2R,3R,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
(1S,2aR,8bR)-1-(hydroxymethyl)-2-[2-(4-morpholinyl)-1-oxoethyl]-N-propyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1R,2aS,8bS)-1-(hydroxymethyl)-2-[2-(4-morpholinyl)-1-oxoethyl]-N-propyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1R,2aR,8bR)-1-(hydroxymethyl)-2-[2-(4-morpholinyl)-1-oxoethyl]-N-propyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(4R)-4-[(5S,8S,9R,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
7alpha,12alpha-Dihydroxy-3-oxochola-1,4-dien-24-oic Acid
yanuthone L
A class I yanuthone that is yanuthone K in which a hydrogen of the pro-E methyl group at the terminus of the farnesyl substituent has been replaced by a hydroxy group. Isolated from the filamentous fungus Aspergillus niger, it shows antifungal activity towards the pathogenic yeast Candida albicans (IC50 = 17.0 +-1.9 muM).
yanuthone X1
A class II yanuthone that is yanuthone X2 in which the hydroxy group at position 4 of the 5,6-epoxycyclohex-2-en-1-one core has been converted to the corresponding acetate ester. Like yanuthone X2, yanuthone X1 has been isolated from the filamentous fungus Aspergillus niger, but shows much lower antifungal activity towards the pathogenic yeast Candida albicans than yanuthone X2 (IC50 >100 muM for yanuthone X1, compared with = 51.7 +-4.7 muM for yanuthone X2).
19-Hydroxybufalin
19-Hydroxybufalin is a bufadienolide, inhibits epithelial-mesenchymal transition and attenuates the migration and invasion of PC3 cells[1].
methyl (1s,2r,5r,10r,11r,13s,14s)-14-hydroxy-2,6,6,10,13-pentamethyl-16-methylidene-7,15-dioxotetracyclo[11.2.1.0²,¹¹.0⁵,¹⁰]hexadecane-1-carboxylate
(1e,10z,12e,15z,17e)-3,20,22-trihydroxy-7-methyl-3,4,5,6,7,14,18a,19,20,21,22,22a-dodecahydro-8-benzoxacycloicosin-9-one
(4bs,8as,9r,10r)-9-(acetyloxy)-10-hydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl acetate
(1r,5r,7s,12s,13s,14s)-13-(acetyloxy)-3,6,6,10,14-pentamethyl-2-oxotricyclo[10.3.0.0⁵,⁷]pentadeca-3,10-dien-1-yl acetate
3-{5-[(2,5-dihydroxy-3-methylphenyl)methyl]-5,6,8a-trimethyl-2-oxo-hexahydro-1h-naphthalen-1-yl}propanoic acid
[(1r,2s,5s,9s,13r)-2-(acetyloxy)-5,9-dimethyl-14-methylidene-6-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methyl acetate
{5-[(acetyloxy)methyl]-1,2-dimethyl-1-(3-methylidenepent-4-en-1-yl)-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-4a-yl}methyl acetate
1-[(1s,4as,11ar)-1-(acetyloxy)-7-methyl-11-methylidene-1h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-4-yl]-4-methylpent-3-en-1-yl acetate
(3s)-2-[(1s,3r,4s,4as)-3-(acetyloxy)-4-methyl-7-methylidene-2,3,4,4a,5,6-hexahydro-1h-naphthalen-1-yl]-6-methyl-4-oxohept-5-en-3-yl acetate
[(3br,5as,6s,9as,9bs)-6-[(acetyloxy)methyl]-3b,6-dimethyl-4h,5h,5ah,7h,8h,9h,9bh,10h,11h-phenanthro[1,2-c]furan-9a-yl]methyl acetate
5-[(1r,3as,3br,5ar,7s,9ar,9bs,11ar)-3a,7-dihydroxy-9a-(hydroxymethyl)-11a-methyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]pyran-2-one
(3r,3as,5r,8ar)-3a-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3,4,5,8-hexahydroazulen-5-yl 3,4-dimethoxybenzoate
(1s,5r,6s,8r)-8-{1-[(1r,3as,8as)-4,4,8a-trimethyl-8-methylidene-hexahydro-1h-azulen-1-yl]ethenyl}-3-oxo-2,7-dioxabicyclo[3.2.1]octan-6-yl acetate
3-(hydroxymethyl)-5-oxo-6-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate
[5-(acetyloxy)-2-(2-methyl-5-oxocyclopent-3-en-1-yl)-3-(6-methylhepta-2,5-dien-2-yl)cyclopentyl]methyl acetate
(1r,2s,3as,4r,12as)-4-(acetyloxy)-3a,6,10-trimethyl-11-oxo-1-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h,12h,12ah-cyclopenta[11]annulen-2-yl acetate
(4as,5r,6s,8ar)-3,4a-dimethyl-5-[(3-methylbutanoyl)oxy]-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-6-yl (2e)-2-methylbut-2-enoate
(2r)-1-(3-acetyl-4-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-2,6-dihydroxy-5-methylphenyl)-2-methylbutan-1-one
(1e,3e,6e,10z)-3-[(acetyloxy)methylidene]-7-methyl-11-(4-methylpent-3-en-1-yl)-12-oxododeca-1,6,10-trien-1-yl acetate
(1r,2s,4s,5s,7r,8r)-3,3,7,9-tetramethyl-5-[(2-methylpropanoyl)oxy]-11-oxotricyclo[5.4.0.0²,⁸]undec-9-en-4-yl (2z)-2-methylbut-2-enoate
(1s,3s,5r,7s,10s,14r,15s,17r,18s)-15-acetyl-7,17-dihydroxy-6,6,10,14,18-pentamethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadec-11-en-13-one
(2r)-2-[(2s,3r,4r)-3,4-dimethyl-5-oxo-3-(6,8,10-trimethyl-9-oxododeca-1,3,5,7-tetraen-1-yl)oxolan-2-yl]propanoic acid
[(1s,2r,3r,5r)-5-(acetyloxy)-2-[(1r,2r)-2-methyl-5-oxocyclopent-3-en-1-yl]-3-[(2z)-6-methylhepta-2,5-dien-2-yl]cyclopentyl]methyl acetate
[(3br,5ar,6s,7s,9ar,9br)-7-(acetyloxy)-3b,6,9a-trimethyl-4h,5h,5ah,7h,8h,9h,9bh,10h,11h-phenanthro[1,2-c]furan-6-yl]methyl acetate
(3r,3as,4s,8ar)-3-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3a,4,5,8-hexahydroazulen-4-yl 3,4-dimethoxybenzoate
methyl 4-hydroxy-3-{[1-(hydroxymethyl)-2,4a-dimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-methoxybenzoate
(1r,3e,5r,7s,10e,12s,13s,14s)-13-(acetyloxy)-3,6,6,10,14-pentamethyl-2-oxotricyclo[10.3.0.0⁵,⁷]pentadeca-3,10-dien-1-yl acetate
4-{[(1s,2r,4ar,8ar)-1-[2-(furan-3-yl)ethyl]-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methoxy}-4-oxobutanoic acid
1β-hydroxybufalin
{"Ingredient_id": "HBIN002411","Ingredient_name": "1\u03b2-hydroxybufalin","Alias": "NA","Ingredient_formula": "C24H34O5","Ingredient_Smile": "CC12CCC3C(C1(CCC2C4=COC(=O)C=C4)O)CCC5C3(C(CC(C5)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9858","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-acetyl-3,5-dihydroxy-1-geranoxy-6-methyl-4-(2-methyl)butyryl-benzene
{"Ingredient_id": "HBIN005123","Ingredient_name": "2-acetyl-3,5-dihydroxy-1-geranoxy-6-methyl-4-(2-methyl)butyryl-benzene","Alias": "AC1NSTGW; 1-[3-Acetyl-2,6-dihydroxy-5-methyl-4-[(3,7-dimethyl-2,6-octadienyl)oxy]phenyl]-2-methyl-1-butanone; 1-[3-acetyl-4-[(2E)-3,7-dimethylocta-2,6-dienoxy]-2,6-dihydroxy-5-methylphenyl]-2-methylbutan-1-one; 2-acetyl-3,5-dihydroxy-1-geranoxy-6-methyl-4-(2-methyl) butyryl-benzene","Ingredient_formula": "C24H34O5","Ingredient_Smile": "CCC(C)C(=O)C1=C(C(=C(C(=C1O)C)OCC=C(C)CCC=C(C)C)C(=O)C)O","Ingredient_weight": "402.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14136;SMIT19036","TCMID_id": "26099","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5315778","DrugBank_id": "NA"}